# Live Enterovirus Vaccine and Type 1 Diabetes

> **NCT02961595** · PHASE1 · COMPLETED · sponsor: **Tampere University** · enrollment: 315 (actual)

## Conditions studied

- Enterovirus Infection
- Type 1 Diabetes
- Prediabetic State

## Interventions

- **BIOLOGICAL:** Oral Polio Vaccine (OPV)

## Key facts

- **NCT ID:** NCT02961595
- **Lead sponsor:** Tampere University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-10
- **Primary completion:** 2016-11
- **Final completion:** 2016-11
- **Target enrollment:** 315 (ACTUAL)
- **Last updated:** 2024-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02961595

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02961595, "Live Enterovirus Vaccine and Type 1 Diabetes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02961595. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*